GH Research PLC (GHRS)
US$ 14.3260.11%
Price Chart
Key Statistics
Market Cap
$ 725.73M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
126.08K
52W High
$ 20.50
52W Low
$ 6.00
Dividend Yield
0.00%
Beta
0.86
Technicals
50-Day MA
10.406
200-Day MA
9.5867
52 Week High
20.5
52 Week Low
6
About GHRS
GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an.
Employees
50
Headquarters
Dublin, Ireland
CEO
Mr. Florian Schonharting M.Sc. (Econ)
Latest News
GH Research (GHRS) Highlights Phase 2b Results at Clinical Confe - GuruFocus
5 days ago • Google News
What Makes GH Research (GHRS) a New Buy Stock - Nasdaq
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg